Skip to main content
Healthcare

STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and more

STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and more

Feed excerpt — reported by STAT News

The health and economic benefits of Covid-19 vaccines far outweighed the costs, with a 60- to 800-fold return on investment, new study found.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.